Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...
ZL-1310, targeting DLL3, shows early antitumor activity in extensive-stage SCLC, with 74% of patients experiencing tumor shrinkage or disappearance. The FDA's fast track designation for ZL-1310 ...
About 40% of people with non-small cell lung cancer (NSCLC)—a type of cancer that begins in the tissues of your lungs—have metastatic disease at the time of their diagnosis. Metastatic NSCLC refers to ...
Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes ...
Hosted on MSN
Oncologist explains different types of lung cancers and which 1 'tends to progress more rapidly than others'
Lung cancer is the leading cause of cancer-related deaths worldwide, accounting for the highest mortality rates among both men and women, as per World Health Organisation. In an interview with HT ...
Ten-year STARS trial data show stereotactic ablative radiotherapy provides survival outcomes comparable to surgery in ...
Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted ...
Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy drug atezolizumab to standard of care concurrent chemoradiation for limited-state small cell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback